fureasu Co., Ltd.

fureasu Co., Ltd.

TTSE:7062
679.00
JPY
+4.00
(+0.59%)
2.11BMarket Cap
Nov 13Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,289.07
1,642.49
1,853.28
1,705.16
1,575.12
1,787.27
1,951.5
2,427.18
3,213.81
2,944.67
- -
Basic EPS, GAAP
79.05
54.96
88.16
24.48
25.44
63.3
13.45
24.78
-103.65
196.21
- -
Free Cash Flow per Basic Share
77.22
-47.41
139.44
-46.36
-50.95
71.23
-134.98
17.82
-197.98
217.63
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
9.25
10.55
10.51
- -
- -
Book Value per Share
264.52
313.38
580.96
643.23
668.51
735.68
733.72
751.29
645.29
835.73
- -
Tangible Book Value per Share
255.88
298.88
566.3
622.06
425.97
503.68
391.01
447.91
383.83
706.76
- -
Basic Weighted Avg Shares
2
2
2
2
2
2
2
2
2
3
3
Sales/Revenue/Turnover
2,900
3,285
3,712
3,963
3,672
4,175
4,584
5,710
7,583
7,638
- -
Operating Margin (%)
5.65
5.01
7.44
1.87
-0.45
4.41
0.32
1.94
-1.39
3.84
- -
Depreciation Expense
6
7
7
18
54
68
97
157
240
189
- -
Net Income, GAAP
178
110
177
57
59
148
32
58
-245
509
- -
Effective Tax Rate (%)
37
35.36
43.77
52.42
47.08
42.79
64.74
52.82
- -
20.85
- -
Profit Margin (%)
6.13
3.35
4.76
1.44
1.62
3.54
0.69
1.02
-3.23
6.66
- -
Working Capital
896
1,330
1,682
1,848
1,908
1,770
1,878
1,795
1,337
2,192
- -
LT Debt
364
726
484
460
806
602
1,668
2,655
4,748
958
- -
Total Equity
595
705
1,307
1,498
1,559
1,719
1,726
1,767
1,548
2,180
- -
Return on Invested Capital (%)
- -
7.14
7.99
1.61
-0.36
3.79
0.16
1.14
- -
3.82
- -
Return on Capital (%)
- -
7.84
9.63
2.77
2.68
5.59
1.11
1.69
- -
9.8
- -
Return on Common Equity (%)
- -
16.91
17.55
4.06
3.88
9.02
1.83
3.34
-14.75
27.3
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
1,357
1,178
- -
LT Borrowings
714
371
- -
LT Finance Leases
602
587
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
2,119
2,113
1,909

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
4,598
4,155
- -
Cash, Cash Equivalents & STI
1,555
1,617
- -
Accounts Receivable, Net
1,465
1,219
- -
Inventories
16
14
- -
Total Current Liabilities
2,357
1,963
- -
Payables & Accruals
- -
- -
- -
ST Debt
1,357
1,178
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
8.29%
40.79%
Free Cash Flow
- -
-415.83%
-220.84%
Net Income, GAAP
- -
-134.47%
-308.1%
Sales/Revenue/Turnover
- -
16.31%
0.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
7,583
2026
- -
- -
- -
- -
7,638
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
-103.65
2026
- -
- -
- -
- -
196.21
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
10.51
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Taku Sawanobori
Full Time Employees
761
Sector
Health services
Industry
Medical/Nursing services
Address
1514 Saijo Tokyo Japan 409-3866
IPO Date
Mar 28, 2019
Website
fureasu.jp
Business
fureasu Co.,Ltd. engages primarily in the operation of massage and home healthcare services in Japan. The company provides insurance-applicable massage services including home acupuncture, moxibustion massage, and office massage; support services for the visually impaired; small-scale multi-functional in-home nursing care encompassing visiting, commuting, and overnight stays; home-visit nursing by nurses and physical therapists; and home-visit caregiving for daily activities such as eating, excretion, and bathing. It operates through directly managed massage parlors, massage franchises, and facility-based care services, with additional SPA services via business alliances with corporate customers. Founded in 2000 and headquartered in Tokyo's Shinagawa-ku at A-PLACE Gotanda, the company employs around 600 staff and focuses on in-home medical support targeting the elderly and those requiring healthcare. In 2025, fureasu completed the sale of portions of its medical care business, including hospices and select small-scale multi-functional home nursing facilities, to Libercare Co., Ltd. for ¥650 million in September, recording a gain of ¥282 million, alongside a prior business succession of specific in-home nursing care stations to HIMEDIC, Inc., a Resorttrust subsidiary, in 2024 to enhance operational synergies.